Reduced ischemia–reperfusion injury with rolipram in rat cadaver lung donors: effect of cyclic adenosine monophosphate
- 1 January 1999
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 67 (1) , 194-199
- https://doi.org/10.1016/s0003-4975(98)01310-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- When does the lung die?K fc, cell viability, and adenine nucleotide changes in the circulation-arrested rat lungJournal of Applied Physiology, 1997
- Reduced Ischemia–Reperfusion Injury with Isoproterenol in Non-Heart-Beating Donor LungsJournal of Surgical Research, 1997
- Pentoxifylline in flush solution improves early lung allograft functionThe Annals of Thoracic Surgery, 1996
- When Does the Lung Die? Time Course of High Energy Phosphate Depletion and Relationship to Lung Viability after "Death"Journal of Surgical Research, 1995
- Rolipram and Isoproterenol Reverse Platelet Activating Factor-Induced Increases in Pulmonary Microvascular Permeability and Vascular ResistanceJournal of Surgical Research, 1995
- Reversal of pulmonary capillary ischemia-reperfusion injury by rolipram, a cAMP phosphodiesterase inhibitorJournal of Applied Physiology, 1994
- Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injuryJournal of Applied Physiology, 1992
- Reversal of increased microvascular permeability associated with ischemia-reperfusion: role of cAMPJournal of Applied Physiology, 1992
- A strategy to increase the donor pool: Use of cadaver lungs for transplantationThe Annals of Thoracic Surgery, 1991
- Role of cyclic adenosine monophosphate in the induction of endothelial barrier propertiesJournal of Cellular Physiology, 1989